BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23275943)

  • 21. Freund's adjuvant, NOD2 and mycobacteria.
    Behr MA; Divangahi M
    Curr Opin Microbiol; 2015 Feb; 23():126-32. PubMed ID: 25483349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The NOD2-RICK complex signals from the plasma membrane.
    Lécine P; Esmiol S; Métais JY; Nicoletti C; Nourry C; McDonald C; Nunez G; Hugot JP; Borg JP; Ollendorff V
    J Biol Chem; 2007 May; 282(20):15197-207. PubMed ID: 17355968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2.
    Lauro ML; D'Ambrosio EA; Bahnson BJ; Grimes CL
    ACS Infect Dis; 2017 Apr; 3(4):264-270. PubMed ID: 27748583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn's disease.
    Bodar E; Netea MG; de Jong DJ; Kullberg BJ; Joosten LA; Van der Meer JW
    Eur Cytokine Netw; 2008 Dec; 19(4):185-9. PubMed ID: 19103524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy.
    Scharl M; Mwinyi J; Fischbeck A; Leucht K; Eloranta JJ; Arikkat J; Pesch T; Kellermeier S; Mair A; Kullak-Ublick GA; Truninger K; Noreen F; Regula J; Gaj P; Pittet V; Mueller C; Hofmann C; Fried M; McCole DF; Rogler G
    Inflamm Bowel Dis; 2012 May; 18(5):900-12. PubMed ID: 22021207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of MDP (muramyl dipeptide)-binding key domains in NOD2 (nucleotide-binding and oligomerization domain-2) receptor of Labeo rohita.
    Maharana J; Swain B; Sahoo BR; Dikhit MR; Basu M; Mahapatra AS; Jayasankar P; Samanta M
    Fish Physiol Biochem; 2013 Aug; 39(4):1007-23. PubMed ID: 23255217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nod2-Rip2 Signaling Contributes to Intestinal Injury Induced by Muramyl Dipeptide Via Oligopeptide Transporter in Rats.
    Ma G; Shi B; Liu J; Zhang H; YinTao Z; Lou X; Liang D; Hou Y; Wan S; Yang W
    Dig Dis Sci; 2015 Nov; 60(11):3264-70. PubMed ID: 26138652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype.
    Borm ME; van Bodegraven AA; Mulder CJ; Kraal G; Bouma G
    Genes Immun; 2008 Apr; 9(3):274-8. PubMed ID: 18340358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1beta production points to a loss-of-function phenotype.
    Netea MG; Ferwerda G; de Jong DJ; Girardin SE; Kullberg BJ; van der Meer JW
    Neth J Med; 2005 Sep; 63(8):305-8. PubMed ID: 16186640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship in NOD2 agonistic muramyl dipeptides.
    Kamboj A; Patil MT; Petrovsky N; Salunke DB
    Eur J Med Chem; 2024 May; 271():116439. PubMed ID: 38691886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
    Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
    Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-κB subunit c-Rel in Paneth cell-like cells.
    Tan G; Liang E; Liao K; Deng F; Zhang W; Chen Y; Xu J; Zhi F
    Oncotarget; 2016 Sep; 7(39):63651-63660. PubMed ID: 27563808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis of NOD2 susceptibility mutations in Crohn's disease.
    Strober W; Kitani A; Fuss I; Asano N; Watanabe T
    Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S5-9. PubMed ID: 19079230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muramyl dipeptide-induced differential gene expression in NOD2 mutant and wild-type Crohn's disease patient-derived dendritic cells.
    Zelinkova Z; van Beelen AJ; de Kort F; Moerland PD; Ver Loren van Themaat E; te Velde AA; van Deventer SJ; de Jong EC; Hommes DW
    Inflamm Bowel Dis; 2008 Feb; 14(2):186-94. PubMed ID: 17941075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates Toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme A expression.
    Masuta Y; Minaga K; Kurimoto M; Sekai I; Hara A; Omaru N; Okai N; Otsuka Y; Takada R; Yoshikawa T; Masaki S; Kamata K; Honjo H; Arai Y; Yamashita K; Kudo M; Watanabe T
    Int Immunol; 2023 Feb; 35(2):79-94. PubMed ID: 36171063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.
    Hiemstra IH; Bouma G; Geerts D; Kraal G; den Haan JM
    Mol Immunol; 2012 Oct; 52(3-4):264-72. PubMed ID: 22750073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of muramyl peptides by NAGK is required for NOD2 activation.
    Stafford CA; Gassauer AM; de Oliveira Mann CC; Tanzer MC; Fessler E; Wefers B; Nagl D; Kuut G; Sulek K; Vasilopoulou C; Schwojer SJ; Wiest A; Pfautsch MK; Wurst W; Yabal M; Fröhlich T; Mann M; Gisch N; Jae LT; Hornung V
    Nature; 2022 Sep; 609(7927):590-596. PubMed ID: 36002575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muramyl Dipeptide Enhances Thermal Injury-Induced Autophagy and Inflammatory Cytokine Response of Lungs via Activation of NOD2/Rick Signaling Pathway in Rats.
    Wu XJ; Liang H; Zhang Y; Yang XM; Wang HY; Li H; Li XY; Chen K; Wang YL; Li JG; Zhang ZZ; Song XM
    Shock; 2018 Nov; 50(5):606-612. PubMed ID: 29215417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists.
    Netea MG; Ferwerda G; de Jong DJ; Werts C; Boneca IG; Jéhanno M; Van Der Meer JW; Mengin-Lecreulx D; Sansonetti PJ; Philpott DJ; Dharancy S; Girardin SE
    J Biol Chem; 2005 Oct; 280(43):35859-67. PubMed ID: 16115863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of Streptococcus pneumoniae and muramyl dipeptide by NOD2 results in potent induction of MMP-9, which can be controlled by lipopolysaccharide stimulation.
    Vissers M; Hartman Y; Groh L; de Jong DJ; de Jonge MI; Ferwerda G
    Infect Immun; 2014 Dec; 82(12):4952-8. PubMed ID: 25183734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.